Insider Trading Update: Dicerna Pharmaceuticals, Inc. $DRNA

90053ea402c4830dbf57593c1505f61b

Dicerna Pharmaceuticals, Inc. (DRNA) insider have most recently took part in a trading activity. On Dec 18, 2017 Bain Capital Life Sciences Investors, Llc, Director, 10% Owner bought 285,000 shares having total worth of $1,995,000 at the price of $7 per share, following the transaction a total of 8,930,237 shares owned by Bain Capital Life Sciences Investors, Llc.

Shares of Dicerna Pharmaceuticals, Inc. (DRNA) traded down 5.46% on Dec 18, 2017, hitting $7.18. 191,663 shares of the company’s stock traded hands. Dicerna Pharmaceuticals, Inc. has a 52 week low of $2.45 and a 52 week high of $9.84. The company’s market cap is $89 million.

Dicerna Pharmaceuticals, Inc. (DRNA) last announced its earnings results on Nov 2, 2017. The company reported -0.92 earnings per share (EPS) for the quarter, lower than the consensus estimate of -0.69 by $0.23. The company had revenue of $0 million for the quarter, compared to the consensus estimate of $0 million. During the same quarter in the previous year, the company posted -0.68 earnings per share. The company’s revenue for the quarter was up 193% on a year-over-year basis.

2017-11-02 2017-08-10 2017-05-08 2017-03-30 2016-11-07 2016-08-04 2016-05-09 2016-03-10 2015-11-10 2015-08-06
earnings per share -0.92 -0.86 -0.68 -0.68 -0.68 -0.75 -0.76 -0.76 -0.71 -0.72
Revenue(M) 0.47 0.25 0.13 0.13 0.16 0 0 0 0 0.18

William White

William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.

About the Author

William White
William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.